Data were missing for some variables in the cohort: maternal age (29.7%); gestational age (33.9%); and childhood vaccinations (21.1%). We carried out a complete case analysis and analysis that included the missing data as a separate category. The results were similar in both models so we have presented AG 14699 the results with

missing data as a separate category. The analyses were restricted to cases with available social deprivation data based on the Townsend score for deprivation quintile [20], therefore excluded 12 women resident in Wales on 1st April 2012 for whom data on area of residence was missing. There were 33,601 women on the NHS AR for the study cohort and time period. Data were available for 30,882 women from the CSW and 24,351 women from the NCCHD (Fig. 1). 14,966/30,882 (48.5%) women had HPV partial or full vaccination and 14,164/30,882 (45.9%) women had attended for cervical screening. 2427/30,882 (7.9%) women had HPV partial vaccination and attended for cervical screening and 5579/30,882 (18.1%) women had HPV full vaccination and attended for cervical screening. Table 1 describes the characteristics of women according buy BI 2536 to HPV vaccine uptake. HPV vaccination status was defined as (i) full HPV vaccination with 3 or more recorded doses (n = 10,109/30,882; 32.7%); (ii) partial HPV vaccination with 1–2 doses (n = 4857/30,882; 15.7%); (iii) not HPV vaccinated

(n = 15,916/30,882; 51.5%). There was a statistically significant relationship between uptake of the HPV vaccine and social deprivation quintile (Table 1). Women from the most affluent quintile (Quintile 1) were more likely to have had partial (19.2%) or full (39.5%) HPV vaccination. Conversely women from the most deprived quintile (Quintile 5) had the highest number of women that had not been HPV vaccinated and the lowest number of women with reported partial and full HPV vaccination (59.2%, 14.4% and 26.3%, respectively). The highest proportion of women not vaccinated was observed for the groups with maternal age under 20 years and 20–24 years (55.4% and 48.7%, respectively) compared to groups whose mothers all were older and this was statistically significant (OR 0.62; 95% CI (0.56, 0.68) and OR 0.80; 95%

CI (0.75, 0.86), respectively). There was no clear relationship between gestational age and HPV vaccination. Table 2 describes the uptake of cervical screening according to characteristics of women. There was a significant relationship between uptake of cervical screening and social deprivation score. Women from the most deprived areas (Quintile 5) were less likely to have attended for cervical screening than women from the least deprived areas (Quintile 1) (41.3% compared to 50.1%, respectively; univariate OR 0.69; 95% CI (0.65, 0.75)). Women who were fully vaccinated were more likely to have attended for cervical screening than women who had not been vaccinated and this was statistically significant (55.2% compared to 38.7%, respectively, OR 0.